Your browser doesn't support javascript.
loading
Role of Physical Activity and Cardiac Rehabilitation in Patients Undergoing Hematopoietic Stem Cell Transplantation.
Mohananey, Divyanshu; Sarau, Alexandra; Kumar, Rohit; Lewandowski, David; Abreu-Sosa, Sol M; Nathan, Sunita; Okwuosa, Tochukwu M.
Afiliação
  • Mohananey D; Department of Cardiovascular Medicine, Medical College of Wisconsin, Wisconsin, USA.
  • Sarau A; Department of Internal Medicine, Rush University, Chicago, Illinois, USA.
  • Kumar R; Hematology and Medical Oncology Division, University of Louisville, Louisville, Kentucky, USA.
  • Lewandowski D; Department of Cardiovascular Medicine, Medical College of Wisconsin, Wisconsin, USA.
  • Abreu-Sosa SM; Department of Physical Medicine and Rehabilitation, Rush University, Chicago, Illinois, USA.
  • Nathan S; Division of Hematology/Oncology and Cell Therapy, Rush University, Chicago, Illinois, USA.
  • Okwuosa TM; Division of Cardiovascular Medicine, Rush University, Chicago, Illinois, USA.
JACC CardioOncol ; 3(1): 17-34, 2021 Mar.
Article em En | MEDLINE | ID: mdl-34396304
Hematopoietic stem cell transplantation (HSCT) is a standard treatment for several malignancies, and >50,000 HSCT are performed annually worldwide. As survival after HSCT improves, cardiovascular disease and associated risk factors have gained importance as a significant cause of morbidity and mortality in this cohort. In this article, we detail the risk factors for cardiovascular disease and their impact in patients undergoing HSCT. Additionally, we critically review the data on the impact of physical exercise in patients undergoing HSCT. Although limited by significant heterogeneity in methodologies, small sample sizes, attrition, and lack of long-term cardiovascular follow-up, most of these studies reinforce the beneficial effects of physical activity and exercise in this patient population. Cardiac rehabilitation (CR) is a structured exercise and lifestyle modification program that is typically instituted in patients who experience acute cardiovascular events. We review the data on CR in the oncologic and nononcologic populations with an aim of building a framework for use of CR in HSCT patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article